Verition Fund Management’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-463
Closed -$42K 2074
2022
Q3
$42K Hold
463
﹤0.01% 2703
2022
Q2
$35K Sell
463
-431
-48% -$26K ﹤0.01% 2179
2022
Q1
$62K Buy
+894
New +$101K ﹤0.01% 2469
2020
Q2
Sell
-6,730
Closed -$2.05M 1041
2020
Q1
$2.05M Buy
6,730
+63
+0.9% +$19.2K 0.08% 162
2019
Q4
$2.02M Sell
6,667
-1,378
-17% -$416K 0.04% 268
2019
Q3
$2.42M Buy
8,045
+3,229
+67% +$968K 0.07% 203
2019
Q2
$1.44M Buy
+4,816
New +$1.43M 0.04% 318

Other funds holding ADN

Verition Fund Management's ADN Position: Q4 2022 in Review

Verition Fund Management sold out of Advent Technologies (ADN) in Q4 2022, closing a stake of 463 shares — an estimated $42K sold.

Verition Fund Management first reported a position in ADN in Q2 2019 and held it in 7 quarters. The position peaked at $2.42M in Q3 2019. 36 funds tracked by Wall St. Rank hold ADN as of Q4 2022.

  • Verition Fund Management reported no remaining Advent Technologies position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 463 Advent Technologies shares in Q4 2022, an estimated $42K.
  • Verition Fund Management first reported a position in Advent Technologies in Q2 2019 and held it in 7 quarters.
  • Verition Fund Management's Advent Technologies position peaked at $2.42M in Q3 2019.
  • 36 funds tracked by Wall St. Rank held Advent Technologies as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.